MedCap AB (publ) (STO:MCAP)
Sweden
· Delayed Price · Currency is SEK 481.00
-9.50 (-1.94%)
At close: Mar 9, 2026
MedCap AB Revenue
In the year 2025, MedCap AB had annual revenue of 2.11B SEK with 16.64% growth. MedCap AB had revenue of 591.00M in the quarter ending December 31, 2025, with 24.50% growth.
Revenue
2.11B
Revenue Growth
+16.64%
P/S Ratio
3.43
Revenue / Employee
3.36M
Employees
627
Market Cap
7.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.11B | 300.70M | 16.64% |
| Dec 31, 2024 | 1.81B | 218.30M | 13.74% |
| Dec 31, 2023 | 1.59B | 465.00M | 41.37% |
| Dec 31, 2022 | 1.12B | 197.70M | 21.34% |
| Dec 31, 2021 | 926.30M | 98.30M | 11.87% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Apr 30, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xvivo Perfusion AB | 812.17M |
| Vitrolife AB | 3.44B |
| Nolato AB | 9.46B |
| CellaVision AB | 748.45M |
| Elekta AB | 17.11B |
| Sectra AB | 3.52B |
| BICO Group AB | 1.50B |
| Paxman AB | 323.56M |
MedCap AB News
- 4 weeks ago - What To Expect From MedCap AB (OSTO:MCAP) Q4 2025 Earnings - GuruFocus